Literature DB >> 26762784

Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord.

Michael Milne1, John C Ashton2.   

Abstract

Cannabinoids produce analgesia through a variety of mechanisms. It has been proposed that one mechanism is by modulating the release of CGRP in the spinal cord pain pathways. Previous studies have reported that cannabinoids, particularly CB2 receptor agonists, can modulate CGRP release in the isolated rat spinal cord. In our experiments, the TRPV1 agonist capsaicin evoked CGRP release and this was supressed by the TRPV1 antagonist capsazepine and by the opioid receptor agonist DAMGO. However, none of the cannabinoid receptor agonists that we tested were able to modulate evoked CGRP release; including WIN 55,212-2, methanandamide, and GW405833. These results question the role of spinal cord cannabinoid receptors in the regulation of CGRP signaling.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  212-2; CGRP; Cannabinoid; DAMGO; Spinal cord; WIN 55,

Mesh:

Substances:

Year:  2016        PMID: 26762784     DOI: 10.1016/j.neulet.2015.12.060

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Activation of the cannabinoid receptor 2 increases renal perfusion.

Authors:  J D Pressly; H Soni; S Jiang; J Wei; R Liu; B M Moore; A Adebiyi; F Park
Journal:  Physiol Genomics       Date:  2019-02-01       Impact factor: 3.107

Review 2.  TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids.

Authors:  Kathleen Louis-Gray; Srinivasan Tupal; Louis S Premkumar
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.